ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Keyword Index

Click a keyword to view all the abstracts on this site tagged with that keyword.

  • citrullination and dendritic cells
  • citrullination and juvenile arthritis
  • citrullination and osteoclastogenesis
  • citrullination and proteomics
  • citrullination and rheumatoid arthritis
  • citrullination and rheumatoid arthritis (RA)
  • citrulline
  • Citrulline and juvenile idiopathic arthritis (JIA)
  • Citrulline and osteoclastogenesis
  • citrulline and rheumatoid arthritis (RA)
  • Citrulline and systemic lupus erythematosus (SLE)
  • CKD
  • ckd and population studies
  • Claims data and Rheumatoid Arthritis
  • CLASI
  • Classical Monocytes
  • classification criteria
  • classification criteria and autoantibodies
  • classification criteria and clinical practice
  • classification criteria and clinical research
  • classification criteria and cross-sectional studies
  • classification criteria and cutaneous lupus erythematosus
  • classification criteria and dermatomyositis
  • classification criteria and diagnosis
  • classification criteria and diagnostic criteria
  • Classification criteria and fibromyalgia
  • Classification criteria and gout
  • classification criteria and inflammation
  • classification criteria and joint
  • Classification criteria and juvenile idiopathic arthritis (JIA)
  • classification criteria and juvenile spondylarthropathy
  • classification criteria and macrophage activation syndrome
  • classification criteria and microbiome
  • classification criteria and muscle biopsy
  • Classification criteria and myositis
  • classification criteria and non-radiographic
  • classification criteria and performance
  • Classification criteria and polymyalgia rheumatica
  • Classification criteria and polymyalgia rhuematica
  • Classification criteria and psoriatic arthritis
  • classification criteria and race/ethnicity
  • Classification criteria and reactive arthritis
  • classification criteria and resolution of disease
  • Classification criteria and rheumatoid arthritis (RA)
  • classification criteria and risk
  • Classification criteria and scleroderma
  • classification criteria and serologic tests
  • classification criteria and spondylarthritis
  • Classification criteria and spondylarthropathy
  • classification criteria and systemic lupus erythematosus (SLE)
  • Classification criteria and systemic sclerosis
  • classification criteria and ultrasonography
  • classification criteria and vasculitis
  • Clinical
  • Clinical and cohort
  • Clinical and Disease Activity
  • Clinical and IgG4
  • Clinical and Musculoskeletal
  • Clinical and SLE
  • Clinical and spondylarthritis
  • Clinical and systemic lupus erythematosus (SLE)
  • Clinical and tocilizumab
  • Clinical Disease activity
  • Clinical Osteoporosis
  • Clinical outcome and drug safety
  • Clinical outcome and Hispanic patients
  • Clinical outcomes
  • Clinical practice
  • clinical practice and clinical practice guidelines
  • clinical practice and diagnosis
  • clinical practice and diagnostic criteria
  • clinical practice and Disease Activity
  • clinical practice and education
  • clinical practice and genetics
  • clinical practice and inflammation
  • Clinical practice and juvenile idiopathic arthritis (JIA)
  • clinical practice and non-radiographic
  • Clinical practice and osteoarthritis
  • clinical practice and outcome measures
  • Clinical practice and patient outcomes
  • clinical practice and patient questionnaires
  • clinical practice and quality improvement
  • clinical practice and rheumatoid arthritis (RA)
  • clinical practice and serologic tests
  • Clinical practice and spondylarthritis
  • clinical practice and systemic lupus erythematosus (SLE)
  • clinical practice and tofacitinib
  • clinical practice and treatment
  • Clinical practice guidelines
  • clinical practice guidelines and health disparities
  • clinical practice guidelines and Lupus
  • clinical practice guidelines and oral
  • clinical practice guidelines and remission
  • Clinical practice guidelines and systemic sclerosis
  • clinical practice guidelines and treatment
  • clinical practice guidelines and tuberculosis
  • Clinical Predictors
  • clinical remission
  • Clinical Remission and quality of life
  • Clinical research
  • clinical research and biomarkers
  • clinical research and clinical trials
  • clinical research and hypertension
  • Clinical research and immunoglobulin (IG)
  • clinical research and infection
  • clinical research and interferons
  • clinical research and interleukins (IL)
  • clinical research and juvenile idiopathic arthritis (JIA)
  • clinical research and laboratory tests
  • clinical research and osteoarthritis
  • clinical research and outcomes
  • Clinical research and pharmacokinetics
  • Clinical research and psoriatic arthritis
  • Clinical research and quality of care
  • clinical research and rheumatoid arthritis (RA)
  • clinical research and RNA
  • clinical research and scleroderma
  • clinical research and socio-economic inequities
  • clinical research and spondylarthritis
  • clinical research and systemic lupus erythematosus (SLE)
  • clinical research and takayasu arteritis
  • clinical research and uveitis
  • clinical research and vasculitis
  • Clinical research methods
  • clinical research methods and African-Americans
  • clinical research methods and minority
  • Clinical Response
  • Clinical Response and adaptive immunity
  • Clinical Response and ankylosing spondylitis (AS)
  • Clinical Response and axial spondyloarthritis
  • Clinical Response and epidemiologic methods
  • Clinical Response and ethics
  • Clinical Response and ethnic studies
  • Clinical Response and fibromyalgia
  • Clinical Response and MicroRNA
  • Clinical Response and psoriatic arthritis
  • Clinical Response and registries
  • Clinical Response and Rheumatoid Factor
  • Clinical Science
  • clinical skills
  • Clinical Study and ADDRESS II
  • clinical trial
  • clinical trials
  • clinical trials and Autoimmune Skin Disease
  • clinical trials and azathioprine
  • clinical trials and biosimilars
  • Clinical trials and dermatomyositis
  • clinical trials and drug treatment
  • Clinical trials and fibromyalgia
  • clinical trials and glucocorticoids
  • clinical trials and juvenile idiopathic arthritis (JIA)
  • clinical trials and laboratory tests
  • clinical trials and lipids
  • clinical trials and lupus nephritis
  • clinical trials and monoclonal antibodies
  • clinical trials and osteoarthritis
  • clinical trials and osteoporosis
  • clinical trials and outcome measures
  • clinical trials and pain
  • clinical trials and polymyalgia rheumatica
  • clinical trials and psoriasis
  • clinical trials and quality
  • clinical trials and randomized trials
  • clinical trials and registries
  • clinical trials and remission
  • clinical trials and renal disease
  • clinical trials and rheumatic disease
  • Clinical trials and rheumatoid arthritis
  • clinical trials and rheumatoid arthritis (RA)
  • clinical trials and rituximab
  • clinical trials and scleroderma
  • clinical trials and statistical methods
  • clinical trials and systemic lupus erythematosus (SLE)
  • clinical trials and systemic sclerosis
  • clinical trials and thrombosis
  • Clinical trials and tocilizumab
  • clinical trials and treatment
  • clinical trials and ulcers
  • clinical trials and vasculitis
  • Clinically Suspect Arthralgia
  • clinically suspect arthralgia and inflammatory arthritis
  • CLK/DYRK inhibitor
  • Clonal Expansion
  • cluster
  • Cmax
  • CMS
  • CMV
  • cno
  • CNS
  • CNS inflammation
  • CNS Lupus
  • CNS Lupus and autoantibodies
  • CNS Lupus and immunoregulation
  • CNS Lupus and Immunotherapy
  • CNS Lupus and magnetic resonance imaging (MRI)
  • CNS Lupus and SLE
  • CNS Vasculitis
  • CNS Vasculitis and spine involvement
  • CNS Vasculitis and treatment
  • Co-morbidities
  • First |
  • « Previous Page
  • 8
  • 9
  • 10
  • 11
  • 12
  • [13]
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next Page »
  • | Last
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences